{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:24:43Z","timestamp":1790630683813,"version":"4.1.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00203-026-04929-z","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:34:11Z","timestamp":1777966451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["mRNA vaccine development for tuberculosis: antigen design, immune mechanisms, and translational challenges"],"prefix":"10.1007","volume":"208","author":[{"given":"Qamar","family":"Abuhassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abu","family":"Shuheil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narinderjit Singh Sawaran","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praharshkumar B.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbulakshmi","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashree","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvinder Singh","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayma Salim","family":"Waleed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakhnozakhon","family":"Muminova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutabar","family":"Latipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilfuza","family":"Begmatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"4929_CR1","doi-asserted-by":"publisher","unstructured":"Aernout I, Verbeke R, De Smedt SC, Impens F, Lentacker I (2024) Current state of mRNA vaccine development against Mycobacterium tuberculosis [Internet]. Trends in mRNA Vaccine Research. Wiley, pp. 325\u201335. https:\/\/doi.org\/10.1002\/9783527838394.ch12","DOI":"10.1002\/9783527838394.ch12"},{"key":"4929_CR2","doi-asserted-by":"publisher","unstructured":"Agrawal N, Ates LS, Schille S, Chaturvedi A, Vogt J, Vukovic N, et al. (2025) mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well-tolerated and efficacious in rodent models [Internet]. openRxiv. https:\/\/doi.org\/10.1101\/2025.09.30.679428","DOI":"10.1101\/2025.09.30.679428"},{"key":"4929_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08506-4","author":"H Al Tbeishat","year":"2022","unstructured":"Al Tbeishat H (2022) Novel in silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-08506-4","journal-title":"Sci Rep"},{"issue":"11","key":"4929_CR4","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1128\/iai.00624-07","volume":"75","author":"J Andersson","year":"2007","unstructured":"Andersson J, Samarina A, Fink J, Rahman S, Grundstr\u00f6m S (2007) Impaired expression of perforin and granulysin in CD8+T cells at the site of infection in human chronic pulmonary tuberculosis. Infect Immun 75(11):5210\u20135222. https:\/\/doi.org\/10.1128\/iai.00624-07","journal-title":"Infect Immun"},{"key":"4929_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-026-01394-z","author":"M Ashayeripanah","year":"2026","unstructured":"Ashayeripanah M (2026) Screening and in silico evaluation of candidate late-stage antigens for incorporation into multi-stage and post-exposure vaccines against tuberculosis. Npj Vaccines. https:\/\/doi.org\/10.1038\/s41541-026-01394-z","journal-title":"Npj Vaccines"},{"key":"4929_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11534-w","author":"M Ashayeripanah","year":"2025","unstructured":"Ashayeripanah M, Kazemi B, Saubi N, Joseph-Munne J, Eftekhar F (2025) Enhanced immunogenicity in mouse by recombinant BCG prime and protein boost based on latency antigen Rv1733c and\/or reactivation antigen RpfE. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-025-11534-w","journal-title":"BMC Infect Dis"},{"key":"4929_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1059725","author":"S Ashenafi","year":"2022","unstructured":"Ashenafi S, Brighenti S (2022) Reinventing the human tuberculosis (TB) granuloma: learning from the cancer field. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1059725","journal-title":"Front Immunol"},{"issue":"4","key":"4929_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ajpath.2021.12.013","volume":"192","author":"S Ashenafi","year":"2022","unstructured":"Ashenafi S, Muvva JR, Mily A, Sn\u00e4ll J, Zewdie M, Chanyalew M et al (2022) Immunosuppressive features of the microenvironment in lymph nodes granulomas from tuberculosis and HIV\u2013co-infected patients. Am J Pathol 192(4):653\u2013670. https:\/\/doi.org\/10.1016\/j.ajpath.2021.12.013","journal-title":"Am J Pathol"},{"issue":"5","key":"4929_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1261\/rna.2309906","volume":"12","author":"JR Babendure","year":"2006","unstructured":"Babendure JR, Babendure JL, Ding JH, Tsien RY (2006) Control of mammalian translation by mRNA structure near caps. RNA 12(5):851\u2013861. https:\/\/doi.org\/10.1261\/rna.2309906","journal-title":"RNA"},{"issue":"4","key":"4929_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biology14040417","volume":"14","author":"O Barazani","year":"2025","unstructured":"Barazani O, Erdos T, Chowdhury R, Kaur G, Venketaraman V (2025) New advances in the development and design of Mycobacterium tuberculosis vaccines: construction and validation of multi-epitope vaccines for tuberculosis prevention. Biology Basel 14(4):417. https:\/\/doi.org\/10.3390\/biology14040417","journal-title":"Biology Basel"},{"issue":"27","key":"4929_CR11","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1016\/j.vaccine.2017.04.007","volume":"35","author":"C Boggiano","year":"2017","unstructured":"Boggiano C, Eichelberg K, Ramachandra L, Shea J, Ramakrishnan L, Behar S et al (2017) \u201cThe impact of Mycobacterium tuberculosis immune evasion on protective immunity: implications for TB vaccine design\u201d \u2013 meeting report. Vaccine 35(27):3433\u20133440. https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.007","journal-title":"Vaccine"},{"issue":"9508","key":"4929_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0140-6736(06)68131-2","volume":"367","author":"GH Bothamley","year":"2006","unstructured":"Bothamley GH (2006) BCG and protection against Mycobacterium tuberculosis infection. Lancet 367(9508):393. https:\/\/doi.org\/10.1016\/s0140-6736(06)68131-2","journal-title":"Lancet"},{"key":"4929_CR13","doi-asserted-by":"publisher","unstructured":"Brosch R (2019) Faculty Opinions recommendation of Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis. [Internet].In: Faculty Opinions \u2013 Post-Publication Peer Review of the Biomedical Literature. H1 Connect. https:\/\/doi.org\/10.3410\/f.734067081.793567693","DOI":"10.3410\/f.734067081.793567693"},{"issue":"26","key":"4929_CR14","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1016\/j.cell.2025.11.023","volume":"188","author":"D Casta\u00f1o","year":"2025","unstructured":"Casta\u00f1o D, Bettini E, Kumar B, Chudnovskiy A, Siv A, Protti G et al (2025) Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses. Cell 188(26):7461-7480.e23. https:\/\/doi.org\/10.1016\/j.cell.2025.11.023","journal-title":"Cell"},{"issue":"9","key":"4929_CR15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41423-020-0502-z","volume":"17","author":"Q Chai","year":"2020","unstructured":"Chai Q, Wang L, Liu CH, Ge B (2020) New insights into the evasion of host innate immunity by Mycobacterium tuberculosis. Cell Mol Immunol 17(9):901\u2013913. https:\/\/doi.org\/10.1038\/s41423-020-0502-z","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"4929_CR16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","volume":"20","author":"P Chandra","year":"2022","unstructured":"Chandra P, Grigsby SJ, Philips JA (2022) Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol 20(12):750\u2013766. https:\/\/doi.org\/10.1038\/s41579-022-00763-4","journal-title":"Nat Rev Microbiol"},{"key":"4929_CR20","doi-asserted-by":"publisher","unstructured":"Chen D, Huang W, Shen L, Zhang J, Pan Z, Zhang C, et al. (2024) A Mrna vaccine induces antimycobacterial immunity by activating DNA damage repair and autophagy [Internet]. Elsevier BV. https:\/\/doi.org\/10.2139\/ssrn.4890661","DOI":"10.2139\/ssrn.4890661"},{"key":"4929_CR17","doi-asserted-by":"publisher","unstructured":"Chen Q, Huang N, Liao M, Zhang X, Aiman S, Li S, et al. (2025a) A novel mi3 VLP nanoparticle vaccine displaying ESAT-6 -PPE57 -PPE68 -EsxV antigens exhibits superior immunogenicity and Mycobacterium tuberculosis growth inhibition [Internet]. Elsevier BV. https:\/\/doi.org\/10.2139\/ssrn.5799306","DOI":"10.2139\/ssrn.5799306"},{"key":"4929_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102402","author":"D Chen","year":"2025","unstructured":"Chen D, Huang W, Shen L, Zhang J, Pan Z, Zhang C et al (2025b) An mRNA vaccine induces antimycobacterial immunity by activating DNA damage repair and autophagy. Mol Ther Nucleic Acids. https:\/\/doi.org\/10.1016\/j.omtn.2024.102402","journal-title":"Mol Ther Nucleic Acids"},{"key":"4929_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1709794","volume":"16","author":"H Chen","year":"2025","unstructured":"Chen H, Gu Y, Song L, Si L (2025c) Next-generation vaccines against bacterial pathogens: mRNA and beyond. Front Immunol 16:1709794. https:\/\/doi.org\/10.3389\/fimmu.2025.1709794","journal-title":"Front Immunol"},{"key":"4929_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34853-x","author":"P Chitale","year":"2022","unstructured":"Chitale P, Lemenze AD, Fogarty EC, Shah A, Grady C, Odom-Mabey AR et al (2022) A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genome. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-022-34853-x","journal-title":"Nat Commun"},{"issue":"1","key":"4929_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00834-y","volume":"9","author":"S Chugh","year":"2024","unstructured":"Chugh S, Bahal RK, Dhiman R, Singh R (2024) Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development. Npj Vaccines 9(1):57","journal-title":"Npj Vaccines"},{"key":"4929_CR23","doi-asserted-by":"publisher","DOI":"10.4110\/in.2021.21.e28","author":"H Chung","year":"2021","unstructured":"Chung H, Kim EA, Chang J (2021) A \u201cprime and deploy\u201d strategy for universal influenza vaccine targeting nucleoprotein induces lung-resident memory CD8 T cells. Immune Netw. https:\/\/doi.org\/10.4110\/in.2021.21.e28","journal-title":"Immune Netw"},{"issue":"6685","key":"4929_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/31159","volume":"393","author":"ST Cole","year":"1998","unstructured":"Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685):537\u2013544. https:\/\/doi.org\/10.1038\/31159","journal-title":"Nature"},{"issue":"9","key":"4929_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1128\/cvi.00271-15","volume":"22","author":"M Coppola","year":"2015","unstructured":"Coppola M, van den Eeden SJF, Wilson L, Franken KLMC, Ottenhoff THM, Geluk A (2015) Synthetic long peptide derived from Mycobacterium tuberculosis latency antigen Rv1733c protects against tuberculosis. Clin Vaccine Immunol 22(9):1060\u20131069. https:\/\/doi.org\/10.1128\/cvi.00271-15","journal-title":"Clin Vaccine Immunol"},{"key":"4929_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.820134","author":"MR Cronan","year":"2022","unstructured":"Cronan MR (2022) In the thick of it: formation of the tuberculous granuloma and its effects on host and therapeutic responses. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.820134","journal-title":"Front Immunol"},{"key":"4929_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151860","volume":"766","author":"Y Cui","year":"2025","unstructured":"Cui Y, Chen T, Zhang Y, Zhang G, Lu C (2025) Capping in mRNA analyzed using Pistol ribozyme and LC-MS. Biochem Biophys Res Commun 766:151860. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151860","journal-title":"Biochem Biophys Res Commun"},{"key":"4929_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1770761","author":"Q Cui","year":"2026","unstructured":"Cui Q, Dou J, Wang F, Jia K (2026) Cell-type specificity of Tim-3 in respiratory diseases: from mechanisms to clinical translation. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2026.1770761","journal-title":"Front Immunol"},{"key":"4929_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.106987","volume":"141","author":"C da Costa","year":"2024","unstructured":"da Costa C, Benn CS, Nyirenda T, Mpabalwani E, Grewal HMS, Ahmed R et al (2024) Perspectives on development and advancement of new tuberculosis vaccines. Int J Infect Dis 141:106987. https:\/\/doi.org\/10.1016\/j.ijid.2024.106987","journal-title":"Int J Infect Dis"},{"key":"4929_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1540359","volume":"16","author":"CJ De Voss","year":"2025","unstructured":"De Voss CJ, Korompis M, Li S, Ateere A, McShane H, Stylianou E (2025) Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis. Front Immunol 16:1540359","journal-title":"Front Immunol"},{"key":"4929_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1609136","author":"L del Pozo-Ramos","year":"2025","unstructured":"del Pozo-Ramos L, Kupz A (2025) A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1609136","journal-title":"Front Immunol"},{"issue":"5","key":"4929_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2217\/17460913.3.5.517","volume":"3","author":"V Deretic","year":"2008","unstructured":"Deretic V (2008) Autophagy, an immunologic magic bullet: Mycobacterium tuberculosis phagosome maturation block and how to bypass it. Future Microbiol 3(5):517\u2013524. https:\/\/doi.org\/10.2217\/17460913.3.5.517","journal-title":"Future Microbiol"},{"issue":"48","key":"4929_CR33","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1016\/j.vaccine.2008.09.011","volume":"26","author":"SC Derrick","year":"2008","unstructured":"Derrick SC, Perera LP, Dheenadhayalan V, Yang A, Kolibab K, Morris SL (2008) The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis. Vaccine 26(48):6092\u20136098. https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.011","journal-title":"Vaccine"},{"key":"4929_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01216-8","author":"Y Ding","year":"2025","unstructured":"Ding Y, Li Y, Wu Z, Zhou Y, Guo Y, Tian S et al (2025) A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv. NPJ Vacc. https:\/\/doi.org\/10.1038\/s41541-025-01216-8","journal-title":"NPJ Vacc"},{"key":"4929_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00712","author":"SN Doddam","year":"2017","unstructured":"Doddam SN, Peddireddy V, Ahmed N (2017) Mycobacterium tuberculosis DosR regulon gene Rv2004c encodes a novel antigen with pro-inflammatory functions and potential diagnostic application for detection of latent tuberculosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.00712","journal-title":"Front Immunol"},{"issue":"1","key":"4929_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.chom.2018.06.004","volume":"24","author":"JD Ernst","year":"2018","unstructured":"Ernst JD (2018) Mechanisms of M. tuberculosis immune evasion as challenges to TB vaccine design. Cell Host Microbe 24(1):34\u201342. https:\/\/doi.org\/10.1016\/j.chom.2018.06.004","journal-title":"Cell Host Microbe"},{"issue":"3","key":"4929_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/156652407780598520","volume":"7","author":"H Fletcher","year":"2007","unstructured":"Fletcher H (2007) Correlates of immune protection from tuberculosis. Curr Mol Med 7(3):319\u2013325. https:\/\/doi.org\/10.2174\/156652407780598520","journal-title":"Curr Mol Med"},{"key":"4929_CR38","doi-asserted-by":"publisher","unstructured":"Franchini G (2021) Decision letter: monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1 [Internet]. eLife Sciences Publications, Ltd. https:\/\/doi.org\/10.7554\/elife.69577.sa1","DOI":"10.7554\/elife.69577.sa1"},{"issue":"9","key":"4929_CR39","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1073\/pnas.0737613100","volume":"100","author":"RA Fratti","year":"2003","unstructured":"Fratti RA, Chua J, Vergne I, Deretic V (2003) Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci U S A 100(9):5437\u20135442","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4929_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127339","volume":"61","author":"RY Gao","year":"2025","unstructured":"Gao RY, Hu T, Taylor AW, Lacey R, Thomas KN, McCormick C et al (2025) Assay for rapid quantification of capped and tailed intact mRNA. Vaccine 61:127339. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127339","journal-title":"Vaccine"},{"issue":"6","key":"4929_CR41","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1128\/iai.01990-06","volume":"75","author":"A Geluk","year":"2007","unstructured":"Geluk A, Lin MY, van Meijgaarden KE, Leyten EMS, Franken KLMC, Ottenhoff THM et al (2007) T-Cell recognition of the HspX protein ofMycobacterium tuberculosis correlates with latentM. tuberculosis infection but not withM. bovis BCG vaccination. Infect Immun 75(6):2914\u20132921. https:\/\/doi.org\/10.1128\/iai.01990-06","journal-title":"Infect Immun"},{"issue":"7\u20138","key":"4929_CR42","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/s0264-410x(01)00450-9","volume":"20","author":"SC Gilbert","year":"2002","unstructured":"Gilbert SC, Schneider J, Hannan CM, Hu JT, Plebanski M, Sinden R et al (2002) Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime\u2013boost immunisation regimes. Vaccine 20(7\u20138):1039\u20131045. https:\/\/doi.org\/10.1016\/s0264-410x(01)00450-9","journal-title":"Vaccine"},{"issue":"1","key":"4929_CR43","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/14760584.2025.2596674","volume":"24","author":"J Haensler","year":"2025","unstructured":"Haensler J, Even L, Wils P, Bensaid F, Dias A, Deng H et al (2025) Not so cold! Improving the thermostability of mRNA vaccines. Expert Rev Vaccines 24(1):1149\u20131162. https:\/\/doi.org\/10.1080\/14760584.2025.2596674","journal-title":"Expert Rev Vaccines"},{"key":"4929_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.tube.2017.11.006","volume":"108","author":"SA Harris","year":"2018","unstructured":"Harris SA, White A, Stockdale L, Tanner R, Sibley L, Sarfas C et al (2018) Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines. Tuberculosis 108:99\u2013105. https:\/\/doi.org\/10.1016\/j.tube.2017.11.006","journal-title":"Tuberculosis"},{"key":"4929_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1039194","volume":"13","author":"M Hassert","year":"2022","unstructured":"Hassert M, Harty JT (2022) Tissue resident memory T cells-a new benchmark for the induction of vaccine-induced mucosal immunity. Front Immunol 13:1039194","journal-title":"Front Immunol"},{"key":"4929_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03154","author":"M Hatherill","year":"2020","unstructured":"Hatherill M, White RG, Hawn TR (2020) Clinical development of new TB vaccines: recent advances and next steps. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2019.03154","journal-title":"Front Microbiol"},{"key":"4929_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01202-0","author":"SL Higham","year":"2025","unstructured":"Higham SL, Wang Z, Murugaiah V, Song J, Thomas C, Zhang H et al (2025) Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung disease. Npj Vaccines. https:\/\/doi.org\/10.1038\/s41541-025-01202-0","journal-title":"Npj Vaccines"},{"issue":"1","key":"4929_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101436","volume":"33","author":"M Hosseini-Kharat","year":"2025","unstructured":"Hosseini-Kharat M, Bremmell KE, Prestidge CA (2025) Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism. Mol Ther Methods Clin Dev 33(1):101436. https:\/\/doi.org\/10.1016\/j.omtm.2025.101436","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"12","key":"4929_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111128","volume":"27","author":"EB Irvine","year":"2024","unstructured":"Irvine EB, Darrah PA, Wang S, Wang C, McNamara RP, Roederer M et al (2024) Humoral correlates of protection against Mycobacterium tuberculosis following intravenous BCG vaccination in rhesus macaques. iScience 27(12):111128. https:\/\/doi.org\/10.1016\/j.isci.2024.111128","journal-title":"iScience"},{"key":"4929_CR50","doi-asserted-by":"publisher","unstructured":"Jalali SR (2025) Review of \u201cInduction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial\u201d [Internet]. ScienceOpen; https:\/\/doi.org\/10.14293\/s2199-1006.1.sor-uncat.a12223143.v1.rtdjbo","DOI":"10.14293\/s2199-1006.1.sor-uncat.a12223143.v1.rtdjbo"},{"issue":"3","key":"4929_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005490","volume":"12","author":"P Jayaraman","year":"2016","unstructured":"Jayaraman P, Jacques MK, Zhu C, Steblenko KM, Stowell BL, Madi A et al (2016) TIM3 mediates T cell exhaustion during Mycobacterium tuberculosis infection. PLoS Pathog 12(3):e1005490","journal-title":"PLoS Pathog"},{"issue":"12","key":"4929_CR52","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41590-022-01354-4","volume":"23","author":"M Jeyanathan","year":"2022","unstructured":"Jeyanathan M, Vaseghi-Shanjani M, Afkhami S, Grondin JA, Kang A, D\u2019Agostino MR et al (2022) Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut\u2013lung axis. Nat Immunol 23(12):1687\u20131702. https:\/\/doi.org\/10.1038\/s41590-022-01354-4","journal-title":"Nat Immunol"},{"key":"4929_CR53","doi-asserted-by":"publisher","unstructured":"Johnston CD (2014) Enhanced expression of codon optimized Mycobacterium avium subsp. paratuberculosis antigens in Lactobacillus salivarius. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2014.00120","DOI":"10.3389\/fcimb.2014.00120"},{"issue":"14","key":"4929_CR54","doi-asserted-by":"publisher","first-page":"8716","DOI":"10.1128\/jvi.79.14.8716-8723.2005","volume":"79","author":"M Kanekiyo","year":"2005","unstructured":"Kanekiyo M, Matsuo K, Hamatake M, Hamano T, Ohsu T, Matsumoto S et al (2005) Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis Bacille Calmette-Gu\u00e9rin expressing Human Immunodeficiency Virus Type 1 Gag. J Virol 79(14):8716\u20138723. https:\/\/doi.org\/10.1128\/jvi.79.14.8716-8723.2005","journal-title":"J Virol"},{"issue":"1","key":"4929_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SHE Kaufmann","year":"2017","unstructured":"Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R (2017) Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov 17(1):35\u201356. https:\/\/doi.org\/10.1038\/nrd.2017.162","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"4929_CR56","doi-asserted-by":"publisher","DOI":"10.7868\/s3034529425060071","volume":"90","author":"AA Kazakova","year":"2025","unstructured":"Kazakova AA (2025) Multiepitope mRNA vaccine mRNA-mEp21-FL-IDT provides effective protection against M. tuberculosis. Biokhimiia 90(6):812. https:\/\/doi.org\/10.7868\/s3034529425060071","journal-title":"Biokhimiia"},{"key":"4929_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1457327","volume":"15","author":"A Kazakova","year":"2024","unstructured":"Kazakova A, Zhelnov P, Sidorov R, Rogova A, Vasileva O, Ivanov R et al (2024) DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies. Front Immunol 15:1457327. https:\/\/doi.org\/10.3389\/fimmu.2024.1457327","journal-title":"Front Immunol"},{"key":"4929_CR58","doi-asserted-by":"publisher","unstructured":"Kelkar NS, Curtis NC, Lahey TP, Wieland-Alter W, Stout JE, Larson EC, et al. (2024) Humoral correlate of vaccine-mediated protection from tuberculosis identified in humans and non-human primates [Internet]. openRxiv. https:\/\/doi.org\/10.1101\/2024.12.05.627012","DOI":"10.1101\/2024.12.05.627012"},{"issue":"8","key":"4929_CR59","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1091\/mbc.e02-12-0780","volume":"14","author":"VA Kelley","year":"2003","unstructured":"Kelley VA, Schorey JS (2003) Mycobacterium\u2019s arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron. Mol Biol Cell 14(8):3366\u20133377. https:\/\/doi.org\/10.1091\/mbc.e02-12-0780","journal-title":"Mol Biol Cell"},{"issue":"23","key":"4929_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313139","volume":"25","author":"A Khlebnikova","year":"2024","unstructured":"Khlebnikova A, Kirshina A, Zakharova N, Ivanov R, Reshetnikov V (2024) Current progress in the development of mRNA vaccines against bacterial infections. Int J Mol Sci 25(23):13139. https:\/\/doi.org\/10.3390\/ijms252313139","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4929_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111300","volume":"40","author":"KQ Kim","year":"2022","unstructured":"Kim KQ, Burgute BD, Tzeng SC, Jing C, Jungers C, Zhang J et al (2022) N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products. Cell Rep 40(9):111300. https:\/\/doi.org\/10.1016\/j.celrep.2022.111300","journal-title":"Cell Rep"},{"issue":"9","key":"4929_CR62","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.1128\/iai.73.9.5666-5674.2005","volume":"73","author":"HJ Ko","year":"2005","unstructured":"Ko HJ, Ko SY, Kim YJ, Lee EG, Cho SN, Kang CY (2005) Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B. Infect Immun 73(9):5666\u20135674. https:\/\/doi.org\/10.1128\/iai.73.9.5666-5674.2005","journal-title":"Infect Immun"},{"issue":"1","key":"4929_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54620-4","volume":"15","author":"KH Ko","year":"2024","unstructured":"Ko KH, Bae HS, Park JW, Lee JS, Park S, Heo J et al (2024) A vaccine platform targeting lung-resident memory CD4\u2009+\u2009T-cells provides protection against heterosubtypic influenza infections in mice and ferrets. Nat Commun 15(1):10368","journal-title":"Nat Commun"},{"key":"4929_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84667-8","author":"M Korompis","year":"2025","unstructured":"Korompis M, De Voss CJ, Li S, Richard A, Almujri SS, Ateere A et al (2025) Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-024-84667-8","journal-title":"Sci Rep"},{"issue":"11","key":"4929_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12111267","volume":"12","author":"A Kozlova","year":"2024","unstructured":"Kozlova A, Pateev I, Shepelkova G, Vasileva O, Zakharova N, Yeremeev V et al (2024) A cap-optimized mRNA encoding multiepitope antigen ESAT6 induces robust cellular and humoral immune responses against Mycobacterium tuberculosis. Vaccines Basel 12(11):1267. https:\/\/doi.org\/10.3390\/vaccines12111267","journal-title":"Vaccines Basel"},{"key":"4929_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-025-01977-w","author":"M Kunc","year":"2025","unstructured":"Kunc M, Whitehead BJ, \u00d8stergaard LJ, Tolstrup M, Benn CS, Wejse CM et al (2025) Signatures of trained immunity following mRNA vaccination: differences between mRNA-1273 and BNT162b2. J Clin Immunol. https:\/\/doi.org\/10.1007\/s10875-025-01977-w","journal-title":"J Clin Immunol"},{"key":"4929_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add3075","volume":"7","author":"M K\u00fcnzli","year":"2022","unstructured":"K\u00fcnzli M, O\u2019Flanagan SD, LaRue M, Talukder P, Dileepan T, Stolley JM et al (2022a) Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells. Sci Immunol 7:eadd3075","journal-title":"Sci Immunol"},{"issue":"78","key":"4929_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add3075","volume":"7","author":"M K\u00fcnzli","year":"2022","unstructured":"K\u00fcnzli M, O\u2019Flanagan SD, LaRue M, Talukder P, Dileepan T, Stolley JM et al (2022b) Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells. Sci Immunol 7(78):eadd3075","journal-title":"Sci Immunol"},{"issue":"22","key":"4929_CR69","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1038\/sj.emboj.7601407","volume":"25","author":"GB Kyei","year":"2006","unstructured":"Kyei GB, Vergne I, Chua J, Roberts E, Harris J, Junutula JR et al (2006) Rab14 is critical for maintenance of Mycobacterium tuberculosis phagosome maturation arrest. EMBO J 25(22):5250\u20135259. https:\/\/doi.org\/10.1038\/sj.emboj.7601407","journal-title":"EMBO J"},{"issue":"12","key":"4929_CR70","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.arbres.2023.09.009","volume":"59","author":"S Lac\u00e1mara","year":"2023","unstructured":"Lac\u00e1mara S, Martin C (2023) MTBVAC: a tuberculosis vaccine candidate advancing towards clinical efficacy trials in TB prevention. Arch Bronconeumol 59(12):821\u2013828. https:\/\/doi.org\/10.1016\/j.arbres.2023.09.009","journal-title":"Arch Bronconeumol"},{"issue":"136","key":"4929_CR71","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1183\/16000617.00002515","volume":"24","author":"R Lai","year":"2015","unstructured":"Lai R, Afkhami S, Haddadi S, Jeyanathan M, Xing Z (2015) Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments. Eur Respir Rev 24(136):356\u2013360","journal-title":"Eur Respir Rev"},{"key":"4929_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00750-7","author":"R Lai","year":"2023","unstructured":"Lai R, Ogunsola AF, Rakib T, Behar SM (2023) Key advances in vaccine development for tuberculosis\u2014success and challenges. Npj Vaccines. https:\/\/doi.org\/10.1038\/s41541-023-00750-7","journal-title":"Npj Vaccines"},{"key":"4929_CR73","doi-asserted-by":"crossref","unstructured":"Larsen SE, Erasmus JH, Reese VA, Pecor T, Archer J, Kandahar A, et al. (2022) RNA-based vaccine demonstrates prophylactic efficacy against Mycobacterium tuberculosis challenge in a mouse model","DOI":"10.1101\/2022.02.23.481669"},{"key":"4929_CR74","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.ijid.2023.03.035","volume":"130","author":"SE Larsen","year":"2023","unstructured":"Larsen SE, Baldwin SL, Coler RN (2023a) Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis? Int J Infect Dis 130:S47-51. https:\/\/doi.org\/10.1016\/j.ijid.2023.03.035","journal-title":"Int J Infect Dis"},{"issue":"1","key":"4929_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010130","volume":"11","author":"SE Larsen","year":"2023","unstructured":"Larsen SE, Erasmus JH, Reese VA, Pecor T, Archer J, Kandahar A et al (2023b) An RNA-based vaccine platform for use against Mycobacterium tuberculosis. Vaccines 11(1):130. https:\/\/doi.org\/10.3390\/vaccines11010130","journal-title":"Vaccines"},{"key":"4929_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adw9184","author":"O Leddy","year":"2025","unstructured":"Leddy O, Ogongo P, Huffaker J, Gan M, Milligan R, Mahmud S et al (2025) Immunopeptidomics can inform the design of mRNA vaccines for the delivery of Mycobacterium tuberculosis MHC class II antigens. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.adw9184","journal-title":"Sci Transl Med"},{"issue":"5","key":"4929_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12050483","volume":"12","author":"F Li","year":"2024","unstructured":"Li F, Dang W, Du Y, Xu X, He P, Zhou Y et al (2024) Tuberculosis vaccines and T cell immune memory. Vaccines 12(5):483. https:\/\/doi.org\/10.3390\/vaccines12050483","journal-title":"Vaccines"},{"issue":"1","key":"4929_CR78","doi-asserted-by":"publisher","first-page":"2469333","DOI":"10.1080\/21645515.2025.2469333","volume":"21","author":"J Li","year":"2025","unstructured":"Li J, Liu D, Li X, Wei J, Du W, Zhao A et al (2025a) RNA vaccines: the dawn of a new age for tuberculosis? Hum Vaccin Immunother 21(1):2469333","journal-title":"Hum Vaccin Immunother"},{"key":"4929_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70414","author":"X Li","year":"2025","unstructured":"Li X, Li J, Wei J, Du W, Su C, Shen X et al (2025b) Design strategies for novel lipid nanoparticle for mRNA vaccine and therapeutics: current understandings and future perspectives. MedComm. https:\/\/doi.org\/10.1002\/mco2.70414","journal-title":"MedComm"},{"issue":"48","key":"4929_CR80","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1016\/j.vaccine.2023.10.026","volume":"41","author":"MM Looney","year":"2023","unstructured":"Looney MM, Hatherill M, Musvosvi M, Flynn J, Kagina BM, Frick M et al (2023) Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine development. Vaccine 41(48):7060\u20137066. https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.026","journal-title":"Vaccine"},{"key":"4929_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105599","author":"H Lukeman","year":"2025","unstructured":"Lukeman H, Al-Wassiti H, Fabb SA, Lim L, Wang T, Britton WJ et al (2025) An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4\u2009+\u2009T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105599","journal-title":"EBioMedicine"},{"key":"4929_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1427559","author":"J Lyu","year":"2024","unstructured":"Lyu J, Narum DE, Baldwin SL, Larsen SE, Bai X, Griffith DE et al (2024) Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1427559","journal-title":"Front Immunol"},{"issue":"4","key":"4929_CR83","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","volume":"58","author":"P Mangtani","year":"2013","unstructured":"Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PEM et al (2013) Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 58(4):470\u2013480. https:\/\/doi.org\/10.1093\/cid\/cit790","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4929_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101149","volume":"4","author":"K Mayer-Blackwell","year":"2023","unstructured":"Mayer-Blackwell K, Ryu H, Codd AS, Parks KR, MacMillan HR, Cohen KW et al (2023) mRNA vaccination boosts S-specific T cell memory and promotes expansion of CD45RAint TEMRA-like CD8\u2009+\u2009T cells in COVID-19 recovered individuals. Cell Rep Med 4(8):101149. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101149","journal-title":"Cell Rep Med"},{"issue":"2","key":"4929_CR85","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41590-021-01121-x","volume":"23","author":"EF McCaffrey","year":"2022","unstructured":"McCaffrey EF, Donato M, Keren L, Chen Z, Delmastro A, Fitzpatrick MB et al (2022) The immunoregulatory landscape of human tuberculosis granulomas. Nat Immunol 23(2):318\u2013329. https:\/\/doi.org\/10.1038\/s41590-021-01121-x","journal-title":"Nat Immunol"},{"issue":"12","key":"4929_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116653","volume":"44","author":"JR Miles","year":"2025","unstructured":"Miles JR, Lu P, Bai S, Aguill\u00f3n-Dur\u00e1n GP, Rodr\u00edguez-Herrera JE, Gunn BM et al (2025) ESAT-6 and CFP-10 reactive IgG in patients with tuberculosis inhibits intracellular bacteria. Cell Rep 44(12):116653. https:\/\/doi.org\/10.1016\/j.celrep.2025.116653","journal-title":"Cell Rep"},{"issue":"10","key":"4929_CR87","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1128\/CVI.00237-09","volume":"16","author":"FA Mir","year":"2009","unstructured":"Mir FA, Kaufmann SHE, Eddine AN (2009) A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire. Clin Vaccine Immunol 16(10):1467\u20131475","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"4929_CR88","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.chom.2017.05.012","volume":"21","author":"AO Moguche","year":"2017","unstructured":"Moguche AO, Musvosvi M, Penn-Nicholson A, Plumlee CR, Mearns H, Geldenhuys H et al (2017) Antigen availability shapes T cell differentiation and function during tuberculosis. Cell Host Microbe 21(6):695-706.e5. https:\/\/doi.org\/10.1016\/j.chom.2017.05.012","journal-title":"Cell Host Microbe"},{"key":"4929_CR89","doi-asserted-by":"publisher","unstructured":"Mohammad Saikat AS (2020) Characterization and functional annotation of uncharacterized ABC transporter ATP-binding protein Rv0986 of Mycobacterium tuberculosis (Strain ATCC 25618 \/ H37Rv) [Internet]. openRxiv. https:\/\/doi.org\/10.1101\/2020.05.23.112680","DOI":"10.1101\/2020.05.23.112680"},{"key":"4929_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51301-0","author":"J Monroe","year":"2024","unstructured":"Monroe J, Eyler DE, Mitchell L, Deb I, Bojanowski A, Srinivas P et al (2024) N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-024-51301-0","journal-title":"Nat Commun"},{"key":"4929_CR91","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2026.2628424","author":"M Moschioni","year":"2026","unstructured":"Moschioni M, Siraji RA, Dissard R, Segafredo G, Mutungi H, Jain A et al (2026) mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts. Hum Vaccin Immunother. https:\/\/doi.org\/10.1080\/21645515.2026.2628424","journal-title":"Hum Vaccin Immunother"},{"key":"4929_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00435","volume":"11","author":"N Naicker","year":"2020","unstructured":"Naicker N, Sigal A, Naidoo K (2020) Metformin as host-directed therapy for TB treatment: scoping review. Front Microbiol 11:00435. https:\/\/doi.org\/10.3389\/fmicb.2020.00435","journal-title":"Front Microbiol"},{"key":"4929_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2024.105703","volume":"127","author":"N Naqvi","year":"2025","unstructured":"Naqvi N, Ahuja Y, Zarin S, Alam A, Ali W, Shariq M et al (2025) BCG\u2019s role in strengthening immune responses: implications for tuberculosis and comorbid diseases. Infect Genet Evol 127:105703. https:\/\/doi.org\/10.1016\/j.meegid.2024.105703","journal-title":"Infect Genet Evol"},{"issue":"2","key":"4929_CR94","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ddstr.2006.05.006","volume":"3","author":"A Nasser Eddine","year":"2006","unstructured":"Nasser Eddine A, Baumann S, Kaufmann SHE (2006) New tuberculosis vaccines approaching clinical trial \u2013 An overview. Drug Discov Today Ther Strateg 3(2):113\u2013119. https:\/\/doi.org\/10.1016\/j.ddstr.2006.05.006","journal-title":"Drug Discov Today Ther Strateg"},{"issue":"6","key":"4929_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130641","volume":"10","author":"H Niu","year":"2015","unstructured":"Niu H, Peng J, Bai C, Liu X, Hu L, Luo Y et al (2015) Multi-stage tuberculosis subunit vaccine candidate LT69 provides high protection against Mycobacterium tuberculosis infection in mice. PLoS ONE 10(6):e0130641. https:\/\/doi.org\/10.1371\/journal.pone.0130641","journal-title":"PLoS ONE"},{"key":"4929_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00992","author":"P Ogongo","year":"2019","unstructured":"Ogongo P, Porterfield JZ, Leslie A (2019) Lung tissue resident memory T-Cells in the immune response to Mycobacterium tuberculosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00992","journal-title":"Front Immunol"},{"issue":"10","key":"4929_CR97","doi-asserted-by":"publisher","DOI":"10.1172\/jci142014","volume":"131","author":"P Ogongo","year":"2021","unstructured":"Ogongo P, Tezera LB, Ardain A, Nhamoyebonde S, Ramsuran D, Singh A et al (2021) Tissue-resident-like CD4\u2009+\u2009t cells secreting IL-17 control Mycobacterium tuberculosis in the human lung. J Clin Invest 131(10):142014. https:\/\/doi.org\/10.1172\/jci142014","journal-title":"J Clin Invest"},{"key":"4929_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114266","volume":"198","author":"M Ongun","year":"2024","unstructured":"Ongun M, Lokras AG, Baghel S, Shi Z, Schmidt ST, Franzyk H et al (2024) Lipid nanoparticles for local delivery of mRNA to the respiratory tract: effect of PEG-lipid content and administration route. Eur J Pharm Biopharm 198:114266. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114266","journal-title":"Eur J Pharm Biopharm"},{"key":"4929_CR99","doi-asserted-by":"publisher","unstructured":"ORME I (2005) Mouse and guinea pig models for testing new tuberculosis vaccines. Tuberculosis [Internet]. https:\/\/doi.org\/10.1016\/j.tube.2004.09.004","DOI":"10.1016\/j.tube.2004.09.004"},{"issue":"3","key":"4929_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13030305","volume":"13","author":"IO Ouh","year":"2025","unstructured":"Ouh IO, Kim MJ, Kim K, Lim H, Yang YJ, Heo JW et al (2025) Bacillus Calmette\u2013Gu\u00e9rin vaccination promotes efficient and comprehensive immune modulation in Guinea Pig models. Vaccines 13(3):305. https:\/\/doi.org\/10.3390\/vaccines13030305","journal-title":"Vaccines"},{"issue":"6","key":"4929_CR101","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1462-5822.2007.00884.x","volume":"9","author":"C Palma","year":"2007","unstructured":"Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G et al (2007) The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1immune response in mice. Cell Microbiol 9(6):1455\u20131465. https:\/\/doi.org\/10.1111\/j.1462-5822.2007.00884.x","journal-title":"Cell Microbiol"},{"key":"4929_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1371596","author":"AI Paremskaia","year":"2024","unstructured":"Paremskaia AI, Kogan AA, Murashkina A, Naumova DA, Satish A, Abramov IS et al (2024) Codon-optimization in gene therapy: promises, prospects and challenges. Front Bioeng Biotechnol. https:\/\/doi.org\/10.3389\/fbioe.2024.1371596","journal-title":"Front Bioeng Biotechnol"},{"key":"4929_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1383098","volume":"15","author":"BBS Passos","year":"2024","unstructured":"Passos BBS, Ara\u00fajo-Pereira M, Vinhaes CL, Amaral EP, Andrade BB (2024) The role of ESAT-6 in tuberculosis immunopathology. Front Immunol 15:1383098. https:\/\/doi.org\/10.3389\/fimmu.2024.1383098","journal-title":"Front Immunol"},{"issue":"6","key":"4929_CR104","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01686-16","volume":"7","author":"C Perdomo","year":"2016","unstructured":"Perdomo C, Zedler U, K\u00fchl AA, Lozza L, Saikali P, Sander LE et al (2016) Mucosal BCG vaccination induces protective lung-resident memory t cell populations against tuberculosis. Mbio 7(6):01686-16. https:\/\/doi.org\/10.1128\/mbio.01686-16","journal-title":"Mbio"},{"issue":"13","key":"4929_CR105","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.micinf.2012.07.001","volume":"14","author":"V Poirier","year":"2012","unstructured":"Poirier V, Av-Gay Y (2012) Mycobacterium tuberculosis modulators of the macrophage\u2019s cellular events. Microbes Infect 14(13):1211\u20131219. https:\/\/doi.org\/10.1016\/j.micinf.2012.07.001","journal-title":"Microbes Infect"},{"key":"4929_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152408","author":"C Pongma","year":"2025","unstructured":"Pongma C, Keawvilai P, Pattarakankul T, Rotcheewaphan S, Alameh MG, Prompetchara E et al (2025) A heterologous prime-boost regimen using BCG and an mRNA encoding Ag85B heightens immune response in mice. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152408","journal-title":"Biochem Biophys Res Commun"},{"key":"4929_CR107","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.4c01854.s001","author":"DO Popoola","year":"2024","unstructured":"Popoola DO, Cao Z, Men Y, Li X, Viapiano M, Wilkens S, Luo J, Teng Y, Meng Q, Li Y (2024) Lung-specific mRNA delivery enabled by sulfonium lipid nanoparticles [Internet]. Am Chem Soc (ACS). https:\/\/doi.org\/10.1021\/acs.nanolett.4c01854.s001","journal-title":"Am Chem Soc (ACS)"},{"key":"4929_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.955204","volume":"9","author":"W Qu","year":"2022","unstructured":"Qu W, Guo Y, Xu Y, Zhang J, Wang Z, Ding C et al (2022) Advance in strategies to build efficient vaccines against tuberculosis. Front Vet Sci 9:955204. https:\/\/doi.org\/10.3389\/fvets.2022.955204","journal-title":"Front Vet Sci"},{"key":"4929_CR109","doi-asserted-by":"publisher","unstructured":"Rappuoli R (2020) Faculty Opinions recommendation of Prevention of tuberculosis in macaques after intravenous BCG immunization. [Internet]. In: Faculty Opinions\u2014Post-Publication Peer Review of the Biomedical Literature. H1 Connect. https:\/\/doi.org\/10.3410\/f.737146359.793569338","DOI":"10.3410\/f.737146359.793569338"},{"key":"4929_CR111","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.tube.2016.09.008","volume":"101","author":"BI Restrepo","year":"2016","unstructured":"Restrepo BI (2016) Metformin: candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients. Tuberculosis 101:S69-72. https:\/\/doi.org\/10.1016\/j.tube.2016.09.008","journal-title":"Tuberculosis"},{"key":"4929_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640168","author":"WF Rijnink","year":"2021","unstructured":"Rijnink WF, Ottenhoff THM, Joosten SA (2021) B-cells and antibodies as contributors to effector immune responses in tuberculosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.640168","journal-title":"Front Immunol"},{"issue":"2","key":"4929_CR113","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/iai.01137-06","volume":"75","author":"V Roupie","year":"2007","unstructured":"Roupie V, Romano M, Zhang L, Korf H, Lin MY, Franken KLMC et al (2007) Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun 75(2):941\u2013949. https:\/\/doi.org\/10.1128\/iai.01137-06","journal-title":"Infect Immun"},{"issue":"8","key":"4929_CR114","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1016\/s2666-5247(23)00184-2","volume":"4","author":"EP Rybicki","year":"2023","unstructured":"Rybicki EP (2023) First WHO\/MPP mRNA Technology Transfer Programme meeting. Lancet Microbe 4(8):e564\u2013e566. https:\/\/doi.org\/10.1016\/s2666-5247(23)00184-2","journal-title":"Lancet Microbe"},{"key":"4929_CR115","doi-asserted-by":"publisher","unstructured":"Saeed TS, Saeed MR, Abdullah MF, Qureshi MS, Saeed A, Munawar S, et al. (2025) Messenger RNA vaccines for tuberculosis prevention: a narrative review of current research and prospects. World J Pharmacol 4(1). https:\/\/doi.org\/10.5497\/wjp.v14.i1.110200","DOI":"10.5497\/wjp.v14.i1.110200"},{"key":"4929_CR116","doi-asserted-by":"crossref","unstructured":"Saeed TS, Saeed MR, Abdullah MF, Qureshi MS, Saeed A (2026) P-1414. mRNA vaccines for tuberculosis prevention: a review of current research and prospects. In: Open Forum Infectious Diseases. Oxford University Press US, pp. ofaf695\u20131601","DOI":"10.1093\/ofid\/ofaf695.1601"},{"key":"4929_CR117","doi-asserted-by":"publisher","unstructured":"Salgame P, Kaipilyawar V (2019) Faculty opinions recommendation of enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1\u2009+\u2009KLRG1- CD4\u2009+\u2009T cells. [Internet]. In: Faculty Opinions \u2013 Post-Publication Peer Review of the Biomedical Literature. H1 Connect. https:\/\/doi.org\/10.3410\/f.734452961.793565361","DOI":"10.3410\/f.734452961.793565361"},{"key":"4929_CR118","doi-asserted-by":"publisher","unstructured":"Schmidt AC, Fairlie L, Hellstr\u00f6m E, Luabeya Kany Kany A, Middelkoop K, Naidoo K, Nair G, Gela A, Nemes E, Scriba TJ, Cinar A (2019) BCG revaccination of healthy adolescents for the prevention of mycobacterium tuberculosis sustained infection. Case Med Res [Internet]. https:\/\/doi.org\/10.31525\/ct1-nct04152161","DOI":"10.31525\/ct1-"},{"issue":"22","key":"4929_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.04.055","volume":"42","author":"KMSR Sefat","year":"2024","unstructured":"Sefat KMSR, Kumar M, Kehl S, Kulkarni R, Leekha A, Paniagua MM et al (2024) An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine 42(22):125909. https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.055","journal-title":"Vaccine"},{"key":"4929_CR120","doi-asserted-by":"publisher","unstructured":"Serra-Vidal MM, Latorre I, Franken KLCM, D\u00c3\u00adaz J, de Souza-Galv\u00c3\u00a3o ML, Casas I, et al. (2014) Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis. Front Microbiol [Internet]. https:\/\/doi.org\/10.3389\/fmicb.2014.00517","DOI":"10.3389\/fmicb.2014.00517"},{"issue":"24","key":"4929_CR121","doi-asserted-by":"publisher","first-page":"6698","DOI":"10.1016\/j.cell.2025.10.024","volume":"188","author":"C Seshadri","year":"2025","unstructured":"Seshadri C (2025) A systematic approach to tuberculosis vaccine development. Cell 188(24):6698\u20136699. https:\/\/doi.org\/10.1016\/j.cell.2025.10.024","journal-title":"Cell"},{"key":"4929_CR122","doi-asserted-by":"publisher","unstructured":"Sharma M, Bhatt P, Singh M, Sharma M, Sharma S (2025) Design and validation of multi-stage expressing mRNA vaccine for Mycobacterium tuberculosis through computational technology [Internet]. Springer Science and Business Media LLC. https:\/\/doi.org\/10.21203\/rs.3.rs-6579802\/v1","DOI":"10.21203\/rs.3.rs-6579802\/v1"},{"issue":"9","key":"4929_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307877","volume":"19","author":"H Shi","year":"2024","unstructured":"Shi H, Zhu Y, Shang K, Tian T, Yin Z, Shi J et al (2024a) Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approaches. PLoS ONE 19(9):e0307877. https:\/\/doi.org\/10.1371\/journal.pone.0307877","journal-title":"PLoS ONE"},{"key":"4929_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02002-z","author":"Y Shi","year":"2024","unstructured":"Shi Y, Shi M, Wang Y, You J (2024b) Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-024-02002-z","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"4929_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12030318","volume":"12","author":"N Silva-Pilipich","year":"2024","unstructured":"Silva-Pilipich N, Beloki U, Salaberry L, Smerdou C (2024) Self-amplifying RNA: a second revolution of mRNA vaccines against COVID-19. Vaccines 12(3):318. https:\/\/doi.org\/10.3390\/vaccines12030318","journal-title":"Vaccines"},{"issue":"6","key":"4929_CR126","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.vaccine.2013.11.065","volume":"32","author":"S Singh","year":"2014","unstructured":"Singh S, Saraav I, Sharma S (2014) Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis. Vaccine 32(6):712\u2013716. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.065","journal-title":"Vaccine"},{"key":"4929_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32376-z","author":"EM Stevenson","year":"2022","unstructured":"Stevenson EM, Terry S, Copertino D, Leyre L, Danesh A, Weiler J et al (2022) SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8\u2009+\u2009T-cells. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-022-32376-z","journal-title":"Nat Commun"},{"issue":"2","key":"4929_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020128","volume":"12","author":"EL Stewart","year":"2024","unstructured":"Stewart EL, Counoupas C, Quan DH, Wang T, Petrovsky N, Britton WJ et al (2024) Lung IL-17A-producing CD4\u2009+\u2009t cells correlate with protection after intrapulmonary vaccination with differentially adjuvanted tuberculosis vaccines. Vaccines 12(2):128. https:\/\/doi.org\/10.3390\/vaccines12020128","journal-title":"Vaccines"},{"key":"4929_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38751-8","author":"W Tai","year":"2023","unstructured":"Tai W, Feng S, Chai B, Lu S, Zhao G, Chen D et al (2023) An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-023-38751-8","journal-title":"Nat Commun"},{"key":"4929_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126648","volume":"45","author":"A Talbot","year":"2025","unstructured":"Talbot A, de Koning-Ward TF, Layton D (2025) Left out in the cold-inequity in infectious disease control due to cold chain disparity. Vaccine 45:126648","journal-title":"Vaccine"},{"issue":"9871","key":"4929_CR131","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/s0140-6736(13)60177-4","volume":"381","author":"MD Tameris","year":"2013","unstructured":"Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S et al (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381(9871):1021\u20131028. https:\/\/doi.org\/10.1016\/s0140-6736(13)60177-4","journal-title":"Lancet"},{"key":"4929_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00332","volume":"10","author":"MZ Tay","year":"2019","unstructured":"Tay MZ, Wiehe K, Pollara J (2019) Antibody-dependent cellular phagocytosis in antiviral immune responses. Front Immunol 10:332","journal-title":"Front Immunol"},{"key":"4929_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126932","volume":"53","author":"S Tengattini","year":"2025","unstructured":"Tengattini S, Bavaro T, Rinaldi F, Temporini C, Pollegioni L, Terreni M et al (2025) Novel tuberculosis vaccines based on TB10.4 and Ag85B: state-of-art and advocacy for good practices. Vaccine 53:126932. https:\/\/doi.org\/10.1016\/j.vaccine.2025.126932","journal-title":"Vaccine"},{"issue":"3","key":"4929_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens15030297","volume":"15","author":"Y Tian","year":"2026","unstructured":"Tian Y, Zhang M, Ali SL, Abduldayeva A, Zhou S, An Y et al (2026) Immunoinformatic design and evaluation of a multi-epitope mRNA vaccine RP14914P targeting latent tuberculosis infection. Pathogens 15(3):297. https:\/\/doi.org\/10.3390\/pathogens15030297","journal-title":"Pathogens"},{"key":"4929_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107446","volume":"152","author":"MBJB Touray","year":"2025","unstructured":"Touray MBJB (2025) mRNA nanovaccine against Mycobacterium tuberculosis elicits robust immunity in mice. Int J Infect Dis 152:107446. https:\/\/doi.org\/10.1016\/j.ijid.2024.107446","journal-title":"Int J Infect Dis"},{"issue":"12","key":"4929_CR136","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1016\/j.ymthe.2025.09.011","volume":"33","author":"JS Tregoning","year":"2025","unstructured":"Tregoning JS, Wang Z, Sridhar S, Shattock RJ, DeRosa F (2025) Immunology of RNA-based vaccines: the critical interplay between inflammation and expression. Mol Ther 33(12):5945\u20135964. https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.011","journal-title":"Mol Ther"},{"issue":"1","key":"4929_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines14010005","volume":"14","author":"AI Tukhvatulin","year":"2025","unstructured":"Tukhvatulin AI, Dzharullaeva AS, Vasina DV, Fursov MV, Izhaeva FM, Kleymenov DA et al (2025) Novel multistage subunit Mycobacterium tuberculosis nanoparticle vaccine confers protection against experimental infection in prophylactic and therapeutic regimens. Vaccines 14(1):5. https:\/\/doi.org\/10.3390\/vaccines14010005","journal-title":"Vaccines"},{"key":"4929_CR138","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00394-25","author":"KE van Meijgaarden","year":"2026","unstructured":"van Meijgaarden KE, Grace PS, Freund NT, Achkar JM, Lindenstr\u00f8m T, Tan J et al (2026) Antibodies in tuberculosis: functional capacity as key determinant. Infect Immun. https:\/\/doi.org\/10.1128\/iai.00394-25","journal-title":"Infect Immun"},{"key":"4929_CR110","doi-asserted-by":"publisher","unstructured":"van Rensburg I, Loxton A (2016) Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease [Internet]. 10.2 Tuberculosis. Eur Respirat Soc, pp. PA2113. https:\/\/doi.org\/10.1183\/13993003.congress-2016.pa2113","DOI":"10.1183\/13993003.congress-2016.pa2113"},{"key":"4929_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1466337","author":"O Vasileva","year":"2024","unstructured":"Vasileva O, Zaborova O, Shmykov B, Ivanov R, Reshetnikov V (2024) Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1466337","journal-title":"Front Pharmacol"},{"issue":"11","key":"4929_CR140","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke R, Hogan MJ, Lor\u00e9 K, Pardi N (2022) Innate immune mechanisms of mRNA vaccines. Immunity 55(11):1993\u20132005. https:\/\/doi.org\/10.1016\/j.immuni.2022.10.014","journal-title":"Immunity"},{"issue":"2","key":"4929_CR141","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1091\/mbc.e03-05-0307","volume":"15","author":"I Vergne","year":"2004","unstructured":"Vergne I, Fratti RA, Hill PJ, Chua J, Belisle J, Deretic V (2004) Mycobacterium tuberculosisphagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol Biol Cell 15(2):751\u2013760. https:\/\/doi.org\/10.1091\/mbc.e03-05-0307","journal-title":"Mol Biol Cell"},{"issue":"24","key":"4929_CR142","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1016\/j.cell.2025.08.027","volume":"188","author":"SJ Vidal","year":"2025","unstructured":"Vidal SJ, Lasrado N, Tostanoski LH, Chaudhari J, Mbiwan ER, Neka GD et al (2025) Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines. Cell 188(24):6791-6803.e13. https:\/\/doi.org\/10.1016\/j.cell.2025.08.027","journal-title":"Cell"},{"issue":"2","key":"4929_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020328","volume":"14","author":"I Vlatkovic","year":"2022","unstructured":"Vlatkovic I, Ludwig J, Boros G, Szab\u00f3 GT, Reichert J, Buff M et al (2022) Ribozyme assays to quantify the capping efficiency of in vitro-transcribed mRNA. Pharmaceutics 14(2):328. https:\/\/doi.org\/10.3390\/pharmaceutics14020328","journal-title":"Pharmaceutics"},{"issue":"1","key":"4929_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-01004-w","volume":"9","author":"J Wang","year":"2024","unstructured":"Wang J, Fan XY, Hu Z (2024) Immune correlates of protection as a game changer in tuberculosis vaccine development. NPJ Vacc 9(1):208","journal-title":"NPJ Vacc"},{"key":"4929_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1246826","author":"AD White","year":"2023","unstructured":"White AD, Tran AC, Sibley L, Sarfas C, Morrison AL, Lawrence S et al (2023) Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1246826","journal-title":"Front Immunol"},{"key":"4929_CR146","doi-asserted-by":"publisher","unstructured":"World Health Organization (2025) WHO consolidated guidelines on tuberculosis. Module 6 [Internet]. World Health Organization. https:\/\/doi.org\/10.2471\/b09457","DOI":"10.2471\/b09457"},{"issue":"7","key":"4929_CR147","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00217-24","volume":"92","author":"C Xander","year":"2024","unstructured":"Xander C, Rajagopalan S, Jacobs WR Jr, Braunstein M (2024) The SapM phosphatase can arrest phagosome maturation in an ESX-1 independent manner in Mycobacterium tuberculosis and BCG. Infect Immun 92(7):e00217-24","journal-title":"Infect Immun"},{"key":"4929_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02107-5","author":"W Xiao","year":"2025","unstructured":"Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W et al (2025) Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-024-02107-5","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4929_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13090959","volume":"13","author":"B Xu","year":"2025","unstructured":"Xu B, Yuan M, Yang L, Huang L, Li J, Tan Z (2025a) Recent advances in clinical research of prophylactic vaccines against tuberculosis. Vaccines 13(9):959. https:\/\/doi.org\/10.3390\/vaccines13090959","journal-title":"Vaccines"},{"key":"4929_CR150","doi-asserted-by":"publisher","unstructured":"Xu X, Cui L, Zhang Y, Gu J (2025b) Deciphering the biological fate of mRNA-LNP-based biologics: a perspective from tissue to intracellular distribution. Acta Pharm Sin B [Internet]. https:\/\/doi.org\/10.1016\/j.apsb.2025.11.023","DOI":"10.1016\/j.apsb.2025.11.023"},{"issue":"3","key":"4929_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100163","volume":"3","author":"Y Yang","year":"2024","unstructured":"Yang Y, Chen YZ, Xia T (2024) Optimizing antigen selection for the development of tuberculosis vaccines. Cell Insight 3(3):100163. https:\/\/doi.org\/10.1016\/j.cellin.2024.100163","journal-title":"Cell Insight"},{"issue":"2","key":"4929_CR152","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","volume":"13","author":"C Young","year":"2020","unstructured":"Young C, Walzl G, Du Plessis N (2020) Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunol 13(2):190\u2013204","journal-title":"Mucosal Immunol"},{"issue":"4","key":"4929_CR153","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11515-018-1494-2","volume":"13","author":"A Yousefi-Avarvand","year":"2018","unstructured":"Yousefi-Avarvand A, Tafaghodi M, Soleimanpour S, Khademi F (2018) HspX protein as a candidate vaccine against Mycobacterium tuberculosis: an overview. Front Biol 13(4):293\u2013296. https:\/\/doi.org\/10.1007\/s11515-018-1494-2","journal-title":"Front Biol"},{"key":"4929_CR154","doi-asserted-by":"publisher","unstructured":"Yun JS, Shin E, Lee YR, Lee JA, Lee H, Kim JS, Shin SJ, Ha SJ, Lee SW, Kim D, Yoo JS (2025) Erratum: Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis. Front Microbiol [Internet]. https:\/\/doi.org\/10.3389\/fmicb.2025.1605861","DOI":"10.3389\/fmicb.2025.1605861"},{"key":"4929_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03060-x","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Du J, Zhang D, Han R, Wu X, Liang Y (2025a) Research progress of mRNA vaccines for infectious diseases. Eur J Med Res. https:\/\/doi.org\/10.1186\/s40001-025-03060-x","journal-title":"Eur J Med Res"},{"key":"4929_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s44149-025-00186-7","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li J, Wang Z, Kuang Y, Li S, Wang X (2025b) Precision-engineered mRNA vaccines: antigen design, structural optimization, and programmable delivery for emerging pathogens. Anim Dis. https:\/\/doi.org\/10.1186\/s44149-025-00186-7","journal-title":"Anim Dis"},{"issue":"12","key":"4929_CR157","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3390\/bioengineering12121378","volume":"12","author":"M Zhang","year":"2025","unstructured":"Zhang M, Ali SL, Tian Y, Abduldayeva A, Zhou S, An Y et al (2025c) EP9158H: an immunoinformatics-designed mRNA vaccine encoding multi-epitope antigens and dual TLR agonists for tuberculosis prevention. Bioengineering 12(12):1378","journal-title":"Bioengineering"},{"issue":"1","key":"4929_CR158","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/22221751.2021.1899771","volume":"10","author":"J Zhou","year":"2021","unstructured":"Zhou J, Lv J, Carlson C, Liu H, Wang H, Xu T et al (2021) Trained immunity contributes to the prevention of Mycobacterium tuberculosis infection, a novel role of autophagy. Emerg Microbes Infect 10(1):578\u2013588. https:\/\/doi.org\/10.1080\/22221751.2021.1899771","journal-title":"Emerg Microbes Infect"},{"issue":"8","key":"4929_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11081304","volume":"11","author":"L Zhuang","year":"2023","unstructured":"Zhuang L, Ye Z, Li L, Yang L, Gong W (2023) Next-generation TB vaccines: progress, challenges, and prospects. Vaccines (Basel) 11(8):1304","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"4929_CR160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007011","volume":"14","author":"KE Zulauf","year":"2018","unstructured":"Zulauf KE, Sullivan JT, Braunstein M (2018) The SecA2 pathway of Mycobacterium tuberculosis exports effectors that work in concert to arrest phagosome and autophagosome maturation. PLoS Pathog 14(4):e1007011. https:\/\/doi.org\/10.1371\/journal.ppat.1007011","journal-title":"PLoS Pathog"},{"issue":"12","key":"4929_CR161","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/pharmaceutics16121582","volume":"16","author":"C Feng","year":"2024","unstructured":"Feng C, Wang Y, Xu J, Zheng Y, Zhou W, Wang Y, Luo C (2024) Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect. Pharmaceutics 16(12):1582. https:\/\/doi.org\/10.3390\/pharmaceutics16121582","journal-title":"Pharmaceutics"},{"issue":"3","key":"4929_CR162","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.matt.2024.01.004","volume":"7","author":"W Wang","year":"2024","unstructured":"Wang W, Li B, Wu Y, Li M, Ma S, Yan D, Liao Y (2024) Macrophage-derived biomimetic nanoparticles for light-driven theranostics toward Mpox. Matter 7(3):1187\u20131206","journal-title":"Matter"},{"issue":"2","key":"4929_CR163","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cclet.2021.08.090","volume":"33","author":"Y Song","year":"2022","unstructured":"Song Y, Huang Y, Zhou F, Ding J, Zhou W (2022) Macrophage-targeted nanomedicine for chronic diseases immunotherapy. Chin Chem Lett 33(2):597\u2013612. https:\/\/doi.org\/10.1016\/j.cclet.2021.08.090","journal-title":"Chin Chem Lett"},{"key":"4929_CR164","doi-asserted-by":"publisher","first-page":"124549","DOI":"10.1016\/j.talanta.2023.124549","volume":"259","author":"S Liu","year":"2023","unstructured":"Liu S, Chen S, Tian L, He Q, Wang X, Lu F, Ning Y (2023) A graphene-oxide-based fluorometric assay for norA gene transcription in MRSA using Nb.BbvCI-assisted target recycling and T7 exonuclease-triggered cascade dual recycling signal amplification. Talanta 259:124549. https:\/\/doi.org\/10.1016\/j.talanta.2023.124549","journal-title":"Talanta"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04929-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04929-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04929-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:13:00Z","timestamp":1782857580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04929-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":164,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4929"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04929-z","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"369"}}